In Bleak Year, Fresenius Revenues Up

Restricted access

During the first three quarters of 2008, Fresenius Medical Care, a renal services company, had a strong showing in its international markets and in the United States. Chief Executive Officer Ben Lipps gave an optimistic assessment for the company in the near future: “Despite cost pressures, an uncertain economic environment, and volatile currency developments, we are confident of achieving our midterm financial targets for 2010.”

As of late 2008, Bad Homburg, Germany-based Fresenius Medical Care had treated 181,937 patients worldwide, mostly in Fresenius-owned clinics, a 6 percent increase compared with a similar period in 2007. The North American market provided